News • Biochemistry

Potential trigger of Crohn’s disease found

Potentially game-changing research led by McMaster University scientists may finally bring relief to millions of people worldwide living with Crohn’s disease.

Photo
Wael Elhenawy in the laboratory

Image source: McMaster

Investigator Brian Coombes said his team identified a strain of adherent-invasive E-coli (AIEC) that is strongly implicated in the condition and is often found in the intestines of people with Crohn’s disease. “If you examine the gut lining of patients with Crohn’s disease, you will find that around 70 to 80 per cent of them test positive for AIEC bacteria, but one of the things we don’t understand is why,” said Coombes, professor and chair of the Department of Biochemistry and Biomedical Sciences, and the Canada Research Chair in Infectious Disease Pathogenesis. “We believe that AIEC is a potential trigger of Crohn’s disease.”

The team’s findings were led by postdoctoral fellow Wael Elhenawy and published in Nature Communications.

Researchers from McMaster and Harvard University made the discovery by mutating every gene in a particular strain of AIEC and testing how these mutants grew in mice. This enabled scientists to pinpoint which genes allowed the bacteria to freely colonize the gut linings of people with Crohn’s disease. AIEC bacteria grow in a biofilm that coats cells lining the intestinal wall, protecting them from both the immune system and antibiotics. The team identified a critical protein structure on the surface of the bacteria that lets them grow in biofilms.

Coombes said Crohn’s disease is caused by the immune system’s inability to “switch off” its inflammatory response to gut bacteria. Symptoms include severe diarrhoea, fatigue, weight loss and malnutrition. Current treatments focus on easing the inflammation, but do not address the root cause of the condition. “New therapies are on the way – we are one step closer to figuring out how this Crohn’s disease-associated bacteria lives in the gut and when we do that, we can develop new treatments,” said Coombes.


Source: McMaster University

06.04.2021

Read all latest stories

Related articles

Photo

News • Intestinal distress

Multiple sclerosis: a closer look at the gut microbiome

​Findings of bacteria with anti-inflammatory effects in the intestines of MS patients with no evidence of active disease indicate that diet, bacteria and disease progression are linked.

Photo

News • Connection between genes and disease severity

E. coli: How does an intestinal germ become a pathogen?

In the human intestine, Escherichia coli is mostly harmless, but in certain conditions causes bladder infections and even sepsis - but why? Researchers went to the bottom of this transformation.

Photo

News • Altered bacterial function

Accumulation of drugs in the gut may reduce their effectiveness

Common medications can accumulate in gut bacteria, a new study has found, altering bacterial function and potentially reducing the medications’ effectiveness. These interactions - seen for many…

Related products

Subscribe to Newsletter